J0690 HCPCS Level II code: Injection, cefazolin sodium, 500 mg
J0690 is the HCPCS code for “Injection, cefazolin sodium, 500 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J0690Injection, cefazolin sodium, 500 mg
Short description: Cefazolin sodium injection
HCPCS · United States
Medicare details
The indicators CMS publishes with J0690 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 1982
Where J0690 sits
- 1J codesDrugs administered other than orally
- 2Active code J0690Injection, cefazolin sodium, 500 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J0690 mean?
J0690 is the HCPCS code for “Injection, cefazolin sodium, 500 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J0690?
CMS lists J0690’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0690
All J codesJ0670Injection, mepivacaine hydrochloride, per 10 mlJ0675Injection, carboprost tromethamine, 0.1 mgJ0681Injection, ceftobiprole medocaril sodium, 3 mgJ0687Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mgJ0688Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mgJ0689Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mgJ0691Injection, lefamulin, 1 mgJ0692Injection, cefepime hydrochloride, 500 mgJ0693Injection, cefiderocol, 5 mgJ0694Injection, cefoxitin sodium, 1 gmJ0695Injection, ceftolozane 50 mg and tazobactam 25 mgJ0696Injection, ceftriaxone sodium, per 250 mg